The relationship between COPD and lung cancer

[1]  Jie He,et al.  Epidemiology of Lung Cancer. , 2016, Surgical oncology clinics of North America.

[2]  Fenghai Duan,et al.  Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy. , 2015, American journal of respiratory and critical care medicine.

[3]  Mohieddin Jafari,et al.  Signaling network of lipids as a comprehensive scaffold for omics data integration in sputum of COPD patients. , 2015, Biochimica et biophysica acta.

[4]  J. Siegfried,et al.  Epigenetic Repression of CCDC37 and MAP1B Links Chronic Obstructive Pulmonary Disease to Lung Cancer , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  M. Socinski,et al.  The Role of Anti-angiogenesis in Non-small-cell Lung Cancer: an Update , 2015, Current Oncology Reports.

[6]  M. Naghavi,et al.  Global and regional trends in COPD mortality, 1990–2010 , 2015, European Respiratory Journal.

[7]  Y. Ung,et al.  Use of the epidermal growth factor receptor inhibitors gefitinib, erlotinib, afatinib, dacomitinib, and icotinib in the treatment of non-small-cell lung cancer: a systematic review. , 2015, Current oncology.

[8]  Yifeng Zhou,et al.  Genetic variant in the 3'-untranslated region of VEGFR1 gene influences chronic obstructive pulmonary disease and lung cancer development in Chinese population. , 2014, Mutagenesis.

[9]  H. Tse,et al.  Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease , 2014, International journal of chronic obstructive pulmonary disease.

[10]  Zhoulei Li,et al.  BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma , 2014, Proceedings of the National Academy of Sciences.

[11]  R. Salgia,et al.  Mitochondrial dynamics: biology and therapy in lung cancer , 2014, Expert opinion on investigational drugs.

[12]  M. Caetano,et al.  T helper 17 cells play a critical pathogenic role in lung cancer , 2014, Proceedings of the National Academy of Sciences.

[13]  E. Larsson,et al.  Antioxidants Accelerate Lung Cancer Progression in Mice , 2014, Science Translational Medicine.

[14]  T. Liloglou,et al.  Epigenetic biomarkers in lung cancer. , 2014, Cancer letters.

[15]  T. Betsuyaku,et al.  Epigenetic clustering of lung adenocarcinomas based on DNA methylation profiles in adjacent lung tissue: Its correlation with smoking history and chronic obstructive pulmonary disease , 2013, International journal of cancer.

[16]  X. Xiang,et al.  Expression and Methylation of Mitochondrial Transcription Factor A in Chronic Obstructive Pulmonary Disease Patients with Lung Cancer , 2013, PloS one.

[17]  Sina Zarrintan,et al.  Prolonged cigarette smoke exposure alters mitochondrial structure and function in airway epithelial cells , 2013, Respiratory Research.

[18]  K. Fong,et al.  Genetic susceptibility to lung cancer and co-morbidities. , 2013, Journal of thoracic disease.

[19]  K. Rabe,et al.  Management of non-small-cell lung cancer: recent developments , 2013, The Lancet.

[20]  M. Ginsberg,et al.  Epidemiology of Lung Cancer , 2013, Seminars in Interventional Radiology.

[21]  Chong Zhang,et al.  Wnt/β-catenin signaling induces the aging of mesenchymal stem cells through promoting the ROS production , 2013, Molecular and Cellular Biochemistry.

[22]  Gentao Liu,et al.  Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis. , 2013, Toxicology.

[23]  Ian M Adcock,et al.  Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. , 2012, American journal of respiratory and critical care medicine.

[24]  S. Ding,et al.  Helicobacter pylori infection induced gastric cancer; advance in gastric stem cell research and the remaining challenges , 2012, Gut Pathogens.

[25]  I. Adcock,et al.  Epigenetics in asthma and COPD. , 2012, Biochimie.

[26]  A. Brandes,et al.  EGF receptor tyrosine kinase inhibitors in the treatment of brain metastases from non-small-cell lung cancer , 2012, Expert review of anticancer therapy.

[27]  J. Neal,et al.  Complex role of histone deacetylase inhibitors in the treatment of non-small-cell lung cancer. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  D. Zagorevski,et al.  The detection of nicotine in a Late Mayan period flask by gas chromatography and liquid chromatography mass spectrometry methods. , 2012, Rapid communications in mass spectrometry : RCM.

[29]  A. Baccarelli,et al.  Variable DNA methylation is associated with chronic obstructive pulmonary disease and lung function. , 2012, American journal of respiratory and critical care medicine.

[30]  I. Adcock,et al.  LPS induced inflammatory responses in human peripheral blood mononuclear cells is mediated through NOX4 and Giα dependent PI-3kinase signalling , 2012, Journal of Inflammation.

[31]  P. Validire,et al.  Telomere dysfunction causes sustained inflammation in chronic obstructive pulmonary disease. , 2011, American journal of respiratory and critical care medicine.

[32]  M. Esteller.  Non-coding RNAs in human disease , 2011, Nature Reviews Genetics.

[33]  I. Adcock,et al.  Chronic obstructive pulmonary disease and lung cancer: a lethal association. , 2011, American journal of respiratory and critical care medicine.

[34]  W. Mitzner,et al.  Telomere length is a determinant of emphysema susceptibility. , 2011, American journal of respiratory and critical care medicine.

[35]  M. Polkey,et al.  Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD , 2011, Thorax.

[36]  R. Wood‐Baker,et al.  Evaluation of epithelial mesenchymal transition in patients with chronic obstructive pulmonary disease , 2011, Respiratory research.

[37]  Eckart Meese,et al.  Specific peripheral miRNA profiles for distinguishing lung cancer from COPD. , 2011, Lung cancer.

[38]  D. Postma,et al.  Activation of WNT / β-Catenin Signaling in Pulmonary Fibroblasts by TGF-β1 Is Increased in Chronic Obstructive Pulmonary Disease , 2011, PloS one.

[39]  Polycarpos Pissis,et al.  Role of oxidative stress and DNA damage in human carcinogenesis. , 2011, Mutation research.

[40]  M. Lu,et al.  Wnt/β-catenin signaling accelerates mouse lung tumorigenesis by imposing an embryonic distal progenitor phenotype on lung epithelium. , 2011, The Journal of clinical investigation.

[41]  I. Adcock,et al.  Unbalanced oxidant-induced DNA damage and repair in COPD: a link towards lung cancer , 2011, Thorax.

[42]  Ian M. Adcock,et al.  Chronic Obstructive Pulmonary Disease and Lung Cancer: New Molecular Insights , 2011, Respiration.

[43]  A. Jemal,et al.  Cancer Statistics, 2010 , 2010, CA: a cancer journal for clinicians.

[44]  V. Kobliakov.  Mechanisms of tumor promotion by reactive oxygen species , 2010, Biochemistry (Moscow).

[45]  I. Adcock,et al.  Treatment effects of low-dose theophylline combined with an inhaled corticosteroid in COPD. , 2010, Chest.

[46]  R. Hopkins,et al.  Link between COPD and lung cancer. , 2010, Respiratory medicine.

[47]  A. Batistatou,et al.  Molecular basis of colorectal cancer. , 2010, The New England journal of medicine.

[48]  Qing Lan,et al.  Genetic variation in telomere maintenance genes, telomere length, and lung cancer susceptibility. , 2009, Lung cancer.

[49]  I. Adcock,et al.  Association of increased CCL5 and CXCL7 chemokine expression with neutrophil activation in severe stable COPD , 2009, Thorax.

[50]  Kazuhiro Ito,et al.  Nitration of distinct tyrosine residues causes inactivation of histone deacetylase 2. , 2009, Biochemical and biophysical research communications.

[51]  A. Liston,et al.  MicroRNA in the immune system, microRNA as an immune system , 2009, Immunology.

[52]  P. Barnes,et al.  COPD as a disease of accelerated lung aging(a). , 2009, Revista portuguesa de pneumologia.

[53]  S. Land,et al.  Cytokine and Cytokine Receptor Single-Nucleotide Polymorphisms Predict Risk for Non–Small Cell Lung Cancer among Women , 2009, Cancer Epidemiology Biomarkers & Prevention.

[54]  B. Housset,et al.  Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.

[55]  Han-Ming Shen,et al.  NFκB signaling in carcinogenesis and as a potential molecular target for cancer therapy , 2009, Apoptosis.

[56]  M. Lindsay,et al.  Role of miRNA-146a in the regulation of the innate immune response and cancer. , 2008, Biochemical Society transactions.

[57]  W. Ajiki,et al.  Lifetime and age-conditional probabilities of developing or dying of cancer in Japan. , 2008, Japanese journal of clinical oncology.

[58]  A. Georgakilas,et al.  Oxidative stress, DNA methylation and carcinogenesis. , 2008, Cancer letters.

[59]  J. Park,et al.  Telomere length and the risk of lung cancer , 2008, Cancer science.

[60]  Manuel Benito,et al.  Telomere shortening is associated with poor prognosis and telomerase activity correlates with DNA repair impairment in non-small cell lung cancer. , 2008, Lung cancer.

[61]  C. Mendelson,et al.  Glucocorticoid/glucocorticoid receptor inhibition of surfactant protein-A (SP-A) gene expression in lung type II cells is mediated by repressive changes in histone modification at the SP-A promoter. , 2008, Molecular endocrinology.

[62]  Florian Kronenberg,et al.  Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years , 2008, BMC Cancer.

[63]  Marco Cattaruzza,et al.  Protein carbonylation and decarboylation: a new twist to the complex response of vascular cells to oxidative stress. , 2008, Circulation research.

[64]  I. Adcock,et al.  Therapeutic Potential of Phosphatidylinositol 3-Kinase Inhibitors in Inflammatory Respiratory Disease , 2007, Journal of Pharmacology and Experimental Therapeutics.

[65]  J. Minna,et al.  A Translational View of the Molecular Pathogenesis of Lung Cancer , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[66]  R. Weinberg,et al.  Telomeres: cancer to human aging. , 2006, Annual review of cell and developmental biology.

[67]  Keara M. Lane,et al.  ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. , 2006, Cancer research.

[68]  D. Harman.  Free Radical Theory of Aging: An Update , 2006, Annals of the New York Academy of Sciences.

[69]  X. Busquets,et al.  Telomere shortening in smokers with and without COPD. , 2006, The European respiratory journal.

[70]  P. Hiemstra,et al.  Expression of epidermal growth factors and their receptors in the bronchial epithelium of subjects with chronic obstructive pulmonary disease. , 2006, American journal of clinical pathology.

[71]  A. Chatterjee,et al.  Oxidized guanine lesions and hOgg1 activity in lung cancer , 2005, Oncogene.

[72]  Li Yu,et al.  [DNA methylation and cancer]. , 2005, Zhonghua nei ke za zhi.

[73]  I. Adcock,et al.  Decreased histone deacetylase activity in chronic obstructive pulmonary disease. , 2005, The New England journal of medicine.

[74]  M. Ginsberg.  Epidemiology of lung cancer. , 2005, Seminars in roentgenology.

[75]  L. Fabbri,et al.  COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma , 2004, Thorax.

[76]  P. Kuna,et al.  Efficacy and safety of inhaled budesonide delivered once or twice daily via HFA-134a in mild to moderate persistent asthma in adult patients. Comparison with budesonide CFC. , 2003, Respiratory medicine.

[77]  M. Spitz,et al.  Telomere dysfunction: a potential cancer predisposition factor. , 2003, Journal of the National Cancer Institute.

[78]  J. Nickoloff,et al.  Oxidative Stress-Induced Homologous Recombination As a Novel Mechanism for Phenytoin-Initiated Toxicity , 2003, Journal of Pharmacology and Experimental Therapeutics.

[79]  C. Harris,et al.  Radical causes of cancer , 2003, Nature Reviews Cancer.

[80]  K Larsson,et al.  Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies. , 2003, Respiratory medicine.

[81]  F. Bosman,et al.  Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity , 2002, International journal of cancer.

[82]  G. O'Connor,et al.  Genetic loci influencing lung function: a genome-wide scan in the Framingham Study. , 2002, American journal of respiratory and critical care medicine.

[83]  E. Silverman,et al.  Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes. , 2002, Human molecular genetics.

[84]  Andrew V. Nguyen,et al.  Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.

[85]  Xifeng Wu,et al.  Analysis of aromatic DNA adducts and 7,8‐dihydro‐8‐oxo‐ 2′‐deoxyguanosine in lymphocyte DNA from a case–control study of lung cancer involving minority populations , 2000, Molecular carcinogenesis.

[86]  P. Kellokumpu-Lehtinen,et al.  Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8‐hydroxy‐2′‐deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment , 1997, FEBS letters.

[87]  W. Pryor.  Cigarette smoke radicals and the role of free radicals in chemical carcinogenicity. , 1997, Environmental health perspectives.

[88]  Y Mao,et al.  Lifetime probability of developing lung cancer, by smoking status, Canada. , 1994, Canadian journal of public health = Revue canadienne de sante publique.

[89]  J. Skokowski,et al.  Oxidative DNA base damage and antioxidant enzyme activities in human lung cancer , 1994 .

[90]  W. Pryor,et al.  Oxidants in Cigarette Smoke Radicals, Hydrogen Peroxide, Peroxynitrate, and Peroxynitrite a , 1993, Annals of the New York Academy of Sciences.

[91]  William A. Pryor,et al.  The Tar Radical ( s ) in Cigarette Smoke : ESR Studies , 2006 .

[92]  Transer Ar.  Types of lung cancer. , 1977 .

[93]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[94]  Ehab Y. Hanna,et al.  Prognosis and Biology in Esthesioneuroblastoma: the Emerging Role of Hyams Grading System , 2014, Current Oncology Reports.

[95]  S. Jang,et al.  ROS1 Receptor Tyrosine Kinase, a Druggable Target, is Frequently Overexpressed in Non-Small Cell Lung Carcinomas Via Genetic and Epigenetic Mechanisms , 2012, Annals of Surgical Oncology.

[96]  G. Joos,et al.  Chronic Obstructive Pulmonary Disease 1 New insights into the immunology of chronic obstructive pulmonary disease , 2011 .

[97]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[98]  A. Schetter,et al.  Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 pathways. , 2010, Carcinogenesis.

[99]  F. Martinez,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. , 2007, American journal of respiratory and critical care medicine.

[100]  A. Schwartz,et al.  Familial lung cancer: genetic susceptibility and relationship to chronic obstructive pulmonary disease. , 2006, American journal of respiratory and critical care medicine.

[101]  M. Aitio.  N-acetylcysteine -- passe-partout or much ado about nothing? , 2006, British journal of clinical pharmacology.

[102]  G. Dranoff,et al.  Cytokines in cancer pathogenesis and cancer therapy , 2004, Nature Reviews Cancer.

[103]  Dafoe Gh.  Southern African AIDS Training Programme. , 1994 .

[104]  K. Albermann,et al.  Nuclear Factor Kb: An Oxidative Stress-Responsive Transcription Factor of Eukaryotic Cells (A Review) , 1992 .

[105]  K. Albermann,et al.  Nuclear factor kappa B: an oxidative stress-responsive transcription factor of eukaryotic cells (a review). , 1992, Free radical research communications.

[106]  H. Hansen,et al.  Lung cancer. , 1990, Cancer chemotherapy and biological response modifiers.

[107]  A. R. Transer.  Types of lung cancer. , 1977, Nursing times.